A phase II study of biweekly carboplatin (Cb) and gemcitabine (G) with bevacizumab (B) as first-line treatment in patients with advanced, inoperable stage IIIb/IV non-squamous non-small cell lung cancer (NSCLC).
2010
e18091 Background: Cb and G is an active platinum doublet used as first line therapy in advanced, inoperable lung cancer. The addition of B to a platinum doublet has shown improved efficacy. A comb...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
1
Citations
NaN
KQI